Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Hirsch

Showing results (71-80 of 141) with videos related to

Pageof 15
Sort By:
Journal of Neurochemistry|July 29, 1998
Striatal expression of glutamic acid decarboxylase gene in Alzheimer's diseaseF Boissière, B Faucheux, C Duyckaerts, et al.
Journal of Neurochemistry|August 3, 2002
Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's diseaseT Breidert, J Callebert, M T Heneka, et al.
Journal of the Neurological Sciences|December 1, 1993
Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's diseaseO Strada, E C Hirsch, F Javoy-Agid, et al.
Journal of Neural Transmission. Supplementum|October 5, 2006
Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae?A Lannuzel, G U Höglinger, P Champy, et al.
Neurology|January 1, 1991
Mesencephalic cholinergic nuclei in progressive supranuclear palsyJ L Juncos, E C Hirsch, S Malessa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated miceH Turmel, A Hartmann, K Parain, et al.
Synapse (New York, N.Y.)|October 23, 2001
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian ratsC Marin, A Jiménez, M Bonastre, et al.
The European Journal of Neuroscience|June 20, 2003
Tremor-related activity of neurons in the 'motor' thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonismD Guehl, M Pessiglione, C François, et al.
Cell Death Discovery|August 24, 2016
Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stressJ Lavaur, M Lemaire, J Pype, et al.
Neuroreport|October 6, 1997
Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's diseaseF Boissière, S Hunot, B Faucheux, et al.
Pageof 15

Showing results (71-80 of 141) with videos related to

Sort By:
Pageof 15
Journal of Neurochemistry|July 29, 1998
Striatal expression of glutamic acid decarboxylase gene in Alzheimer's diseaseF Boissière, B Faucheux, C Duyckaerts, et al.
Journal of Neurochemistry|August 3, 2002
Protective action of the peroxisome proliferator-activated receptor-gamma agonist pioglitazone in a mouse model of Parkinson's diseaseT Breidert, J Callebert, M T Heneka, et al.
Journal of the Neurological Sciences|December 1, 1993
Low affinity nerve growth factor receptor, adrenal transplant and Parkinson's diseaseO Strada, E C Hirsch, F Javoy-Agid, et al.
Journal of Neural Transmission. Supplementum|October 5, 2006
Is atypical parkinsonism in the Caribbean caused by the consumption of Annonacae?A Lannuzel, G U Höglinger, P Champy, et al.
Neurology|January 1, 1991
Mesencephalic cholinergic nuclei in progressive supranuclear palsyJ L Juncos, E C Hirsch, S Malessa, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|April 11, 2001
Caspase-3 activation in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated miceH Turmel, A Hartmann, K Parain, et al.
Synapse (New York, N.Y.)|October 23, 2001
LY293558, an AMPA glutamate receptor antagonist, prevents and reverses levodopa-induced motor alterations in Parkinsonian ratsC Marin, A Jiménez, M Bonastre, et al.
The European Journal of Neuroscience|June 20, 2003
Tremor-related activity of neurons in the 'motor' thalamus: changes in firing rate and pattern in the MPTP vervet model of parkinsonismD Guehl, M Pessiglione, C François, et al.
Cell Death Discovery|August 24, 2016
Xenon-mediated neuroprotection in response to sustained, low-level excitotoxic stressJ Lavaur, M Lemaire, J Pype, et al.
Neuroreport|October 6, 1997
Nuclear translocation of NF-kappaB in cholinergic neurons of patients with Alzheimer's diseaseF Boissière, S Hunot, B Faucheux, et al.
Pageof 15